Guth has Friedreich’s Ataxia and chose to raise money at Happy Place Nutrition for Friedreich’s Ataxia Research Alliance ...

The global Friedreich’s ataxia market is experiencing notable growth, fueled by advancements in genetic research, enhanced diagnostic technologies, and increased awareness of this rare ...

Since July, several biotechs have been forced to pivot as previous agreements with the FDA around evidence required for approval were reversed, a phenomenon that, according to experts, could portend a ...

One horse in Northumberland County, Pennsylvania, has tested positive for equine herpesvirus-4 (EHV-4), the respiratory form ...

Larimar Therapeutics ( ($LRMR) ) has provided an update. On November 10, 2025, Larimar Therapeutics announced an updated slide presentation ...

The FDA has issued a CRL to Biohaven regarding the NDA for troriluzole for the treatment of adults with spinocerebellar ataxia.

As of November 23, the EDCC has confirmed 27 EHV-1 cases associated with the event. The cases are located in Texas, Oklahoma, Louisiana, Colorado, New Mexico, Washington, and Arizona. McLennan County: ...

(Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the positive outcome of its ...

Larimar Therapeutics, Inc. ( (LRMR)) has released its Q3 earnings. Here is a breakdown of the information Larimar Therapeutics, Inc. presented to its investors. Larimar Therapeutics, Inc. is a ...

As Katie Powers prepared to have “a simple procedure” to remove a benign tumor on her brain, she looked forward to returning ...

Lexeo Therapeutics, Inc. surges after FDA trial alignment for LX2006 in Friedreich’s ataxia. Click for more on LXEO stock following its Q3 earnings release.

A fast-spreading horse virus is forcing West Texas owners, arenas and officials to tighten precautions to prevent a ...